Zanubrutinib
Acalabrutinib
Obinutuzumab
Update Venetoclax in CLL
NCCN COVID-19 Resources Page
NCCN Guidelines for Patients
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Guidelines for Patients for CLL